Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of chlorpyrifos and acephate on the web-building behavior of Argiope trifasciata.

Brazilian journal of biology = Revista brasleira de biologia·2026

Same author

Diagnostic value of SPECT for endocarditis: a systematic review and meta-analysis.

Clinical radiology·2025

Same author

Suicide in head and neck oncology.

European annals of otorhinolaryngology, head and neck diseases·2023

Same author

A "royal" total laryngectomy that never was.

European annals of otorhinolaryngology, head and neck diseases·2023

Same author

The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom.

Rhinology·2022

Same author

Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey.

Vacunas·2021

Same journal

Re: "Aorto-duodenal fistula: what should we do?"

Journal of visceral surgery·2026

Same journal

Transgastric singleport laparoscopic resection of a gastroesophageal junction stromal tumor (with video).

Journal of visceral surgery·2026

Same journal

Revascularization of the hepatic artery by reimplantation of the gastroduodenal artery during a pancreatoduodenectomy (with video).

Journal of visceral surgery·2026

Same journal

Surgery is no longer the only effective treatment for obesity: What does this means?

Journal of visceral surgery·2026

Same journal

The GRADE approach explained to surgeons.

Journal of visceral surgery·2026

Same journal

Role of laparoscopy in the management of abdominal trauma.

Journal of visceral surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 27, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Initial experience using robot- assisted transaxillary thyroidectomy for Graves' disease.

E Kandil¹, S Noureldine, M Abdel Khalek

¹Department of Surgery, Endocrine and Oncological Surgery Division, New Orleans, LA, USA. ekandil@tulane.edu

Journal of Visceral Surgery

|November 29, 2011

Summary

This summary is machine-generated.

Robotic transaxillary thyroidectomy is a safe and effective surgical option for Graves' disease, overcoming limitations of traditional endoscopic methods. This approach demonstrates feasibility in managing this challenging hyperthyroidism condition.

More Related Videos

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

Related Experiment Videos

Last Updated: May 27, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

Area of Science:

Endocrinology
Surgical Oncology
Robotic Surgery

Background:

Graves' disease is a common cause of hyperthyroidism requiring thyroidectomy.
Endoscopic thyroidectomy is often contraindicated in Graves' disease due to gland size and vascularity.
Robotic surgery may offer advantages in overcoming these challenges.

Purpose of the Study:

To evaluate the feasibility and safety of robotic transaxillary subtotal thyroidectomy in patients with Graves' disease.
To determine if robotic surgery can overcome limitations of conventional endoscopic techniques in this patient population.

Main Methods:

Prospective study conducted at an academic hospital.
Robotic transaxillary thyroidectomy performed on 67 patients over one year.
Five of these patients underwent the procedure for Graves' disease.

Main Results:

No conversions to open or laparoscopic surgery were required.
Mean operative time was 159 minutes; mean docking time was 81 minutes.
Mean blood loss was 18 mL, with no perioperative complications or vocal cord issues.

Conclusions:

Robotic transaxillary thyroidectomy is a feasible, safe, and effective approach for Graves' disease.
This study represents the first description of this technique for Graves' disease.
Further prospective clinical trials are warranted to validate these findings.